Literature DB >> 17346281

In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection.

Yan Zhang1, Diana L Wallace, Catherine M de Lara, Hala Ghattas, Becca Asquith, Andrew Worth, George E Griffin, Graham P Taylor, David F Tough, Peter C L Beverley, Derek C Macallan.   

Abstract

Human natural killer (NK) cells form a circulating population in a state of dynamic homeostasis. We investigated NK cell homeostasis by labelling dividing cells in vivo using deuterium-enriched glucose in young and elderly healthy subjects and patients with viral infection. Following a 24-hr intravenous infusion of 6,6-D(2)-glucose, CD3(-) CD16(+) NK cells sorted from peripheral blood mononuclear cells (PBMC) by fluorescence-activated cell sorter (FACS) were analysed for DNA deuterium content by gas chromatography mass spectrometry to yield minimum estimates for proliferation rate (p). In healthy young adults (n=5), deuterium enrichment was maximal approximately 10 days after labelling, consistent with postmitotic maturation preceding circulation. The mean (+/- standard deviation) proliferation rate was 4 x 3 +/- 2 x 4%/day (equivalent to a doubling time of 16 days) and the total production rate was 15 +/- (7 x 6) x 10(6) cells/l/day. Labelled cells disappeared from the circulation at a similar rate [6 x 9 +/- 4 x 0%/day; half-life (T((1/2))) < 10 days]. Healthy elderly subjects (n=8) had lower proliferation and production rates (P=2 x 5 +/- 1 x 0%/day and 7 x 3 +/- (3 x 7) x 10(6) cells/l/day, respectively; P=0 x 04). Similar rates were seen in patients chronically infected with human T-cell lymphotropic virus type I (HTLV-I) (P=3 x 2 +/- 1 x 9%/day). In acute infectious mononucleosis (n=5), NK cell numbers were increased but kinetics were unaffected (P=2 x 8 +/- 1 x 0%/day) a mean of 12 days after symptom onset. Human NK cells have a turnover time in blood of about 2 weeks. Proliferation rates appear to fall with ageing, remain unperturbed by chronic HTLV-I infection and normalize rapidly following acute Epstein-Barr virus infection.

Entities:  

Mesh:

Year:  2007        PMID: 17346281      PMCID: PMC2265941          DOI: 10.1111/j.1365-2567.2007.02573.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.

Authors:  H Mohri; A S Perelson; K Tung; R M Ribeiro; B Ramratnam; M Markowitz; R Kost; A Hurley; L Weinberger; D Cesar; M K Hellerstein; D D Ho
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

2.  Specific and nonspecific NK cell activation during virus infection.

Authors:  A O Dokun; S Kim; H R Smith; H S Kang; D T Chu; W M Yokoyama
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

3.  Natural killer cells in the late decades of human life.

Authors:  K Ogata; N Yokose; H Tamura; E An; K Nakamura; K Dan; T Nomura
Journal:  Clin Immunol Immunopathol       Date:  1997-09

4.  Analysis of in situ NK cell responses during viral infection.

Authors:  A O Dokun; D T Chu; L Yang; A S Bendelac; W M Yokoyama
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

5.  Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.

Authors:  Jia-Wang Wang; Julie M Howson; Tomar Ghansah; Caroline Desponts; John M Ninos; Sarah L May; Kim H T Nguyen; Noriko Toyama-Sorimachi; William G Kerr
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

6.  IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity.

Authors:  Marion T Kasaian; Matthew J Whitters; Laura L Carter; Leslie D Lowe; Jason M Jussif; Bijia Deng; Kaley A Johnson; JoAnn S Witek; Mayra Senices; Richard F Konz; Andrea L Wurster; Debra D Donaldson; Mary Collins; Deborah A Young; Michael J Grusby
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

7.  Age-associated alterations in human natural killer cells. 2. Increased frequency of selective NK subsets.

Authors:  R Krishnaraj; G Blandford
Journal:  Cell Immunol       Date:  1988-06       Impact factor: 4.868

8.  Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset.

Authors:  A Galy; M Travis; D Cen; B Chen
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

9.  In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells.

Authors:  Megan A Cooper; Jennifer E Bush; Todd A Fehniger; Jeffrey B VanDeusen; Ross E Waite; Yang Liu; Hector L Aguila; Michael A Caligiuri
Journal:  Blood       Date:  2002-07-05       Impact factor: 22.113

10.  X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.

Authors:  S Parolini; C Bottino; M Falco; R Augugliaro; S Giliani; R Franceschini; H D Ochs; H Wolf; J Y Bonnefoy; R Biassoni; L Moretta; L D Notarangelo; A Moretta
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

View more
  106 in total

1.  Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Authors:  Philip J Norris; Dale F Hirschkorn; Deborah A DeVita; Tzong-Hae Lee; Edward L Murphy
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

Review 2.  Innate immunity and aging.

Authors:  Christian R Gomez; Vanessa Nomellini; Douglas E Faunce; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2008-06-11       Impact factor: 4.032

Review 3.  Factors affecting immune responses to the influenza vaccine.

Authors:  Maria R Castrucci
Journal:  Hum Vaccin Immunother       Date:  2017-07-21       Impact factor: 3.452

Review 4.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 5.  Clinical utility of natural killer cells in cancer therapy and transplantation.

Authors:  David A Knorr; Veronika Bachanova; Michael R Verneris; Jeffrey S Miller
Journal:  Semin Immunol       Date:  2014-03-05       Impact factor: 11.130

6.  The effects of 1,25-dihydroxyvitamin D3 on in vitro human NK cell development from hematopoietic stem cells.

Authors:  Matthew A Weeres; Kim Robien; Yong-Oon Ahn; Marie-Luise Neulen; Rachel Bergerson; Jeffery S Miller; Michael R Verneris
Journal:  J Immunol       Date:  2014-08-22       Impact factor: 5.422

7.  Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.

Authors:  E Liu; Y Tong; G Dotti; H Shaim; B Savoldo; M Mukherjee; J Orange; X Wan; X Lu; A Reynolds; M Gagea; P Banerjee; R Cai; M H Bdaiwi; R Basar; M Muftuoglu; L Li; D Marin; W Wierda; M Keating; R Champlin; E Shpall; K Rezvani
Journal:  Leukemia       Date:  2017-07-20       Impact factor: 11.528

8.  Factors that may impact on immunosenescence: an appraisal.

Authors:  Joseph Ongrádi; Valéria Kövesdi
Journal:  Immun Ageing       Date:  2010-06-14       Impact factor: 6.400

Review 9.  Health-and disease-related biomarkers in aging research.

Authors:  Hilaire J Thompson; Joachim G Voss
Journal:  Res Gerontol Nurs       Date:  2009-04       Impact factor: 1.571

10.  Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection.

Authors:  Obinna Chijioke; Anne Müller; Regina Feederle; Mario Henrique M Barros; Carsten Krieg; Vanessa Emmel; Emanuela Marcenaro; Carol S Leung; Olga Antsiferova; Vanessa Landtwing; Walter Bossart; Alessandro Moretta; Rocio Hassan; Onur Boyman; Gerald Niedobitek; Henri-Jacques Delecluse; Riccarda Capaul; Christian Münz
Journal:  Cell Rep       Date:  2013-12-19       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.